Tenaya Therapeutics Inc (NASDAQ: TNYA) established initial surge of 20.17% at $0.87, as the Stock market unbolted on Thursday, before settling in for the price of $0.72 at the close. Taking a more long-term approach, TNYA posted a 52-week range of $0.36-$4.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -15.48% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -15.48%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 38.24%. This publicly-traded company’s shares outstanding now amounts to $162.66 million, simultaneously with a float of $134.18 million. The organization now has a market capitalization sitting at $140.89 million. At the time of writing, stock’s 50-day Moving Average stood at $0.5605, while the 200-day Moving Average is $1.2310.
Tenaya Therapeutics Inc (TNYA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Tenaya Therapeutics Inc industry. Tenaya Therapeutics Inc’s current insider ownership accounts for 17.51%, in contrast to 27.53% institutional ownership. According to the most recent insider trade that took place on May 16 ’25, this organization’s SVP, Finance sold 1,390 shares at the rate of 0.44, making the entire transaction reach 615 in total value, affecting insider ownership by 98,300. Preceding that transaction, on May 16 ’25, Company’s Chief Medical Officer sold 2,937 for 0.44, making the whole transaction’s value amount to 1,300. This particular insider is now the holder of 171,856 in total.
Tenaya Therapeutics Inc (TNYA) Earnings and Revenue Records
Tenaya Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 38.24% and is forecasted to reach -0.71 in the upcoming year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Let’s observe the current performance indicators for Tenaya Therapeutics Inc (TNYA). It’s Quick Ratio in the last reported quarter now stands at 6.68.
In the same vein, TNYA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.16, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.71 at the market close of one year from today.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Now, what If we examine the latest scores posted by [Tenaya Therapeutics Inc, TNYA]. During the last 5-days, its volume was better the volume of 2.85 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 81.94% While, its Average True Range was 80.69%.
Raw Stochastic average of Tenaya Therapeutics Inc (TNYA) in the period of the previous 100 days is set at 62.48%, which indicates a major fall in contrast to 98.65% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0554 that was lower than 0.0592 volatility it exhibited in the past 100-days period.
